tiprankstipranks
TipRanksTop Financial ExpertsInsidersJulie Smith

Julie Smith Insider Profile

4 Followers
Julie Smith, Director at Stoke Therapeutics, holds ― shares in Stoke Therapeutics (Ticker: STOK), holds 28.96K shares in Exelixis (Ticker: EXEL), holds 37.95K shares in Raptor Pharmaceutical Corp. (Ticker: RPTP). Most recently, Julie Smith ― shares of Stoke Therapeutics on ― for an estimated value of ―.
See the Hottest Stocks Based on Insider Trading >
tipranks
Julie Smith

Julie Smith
Stoke Therapeutics (STOK)
Director

Ranked #98,726 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-47.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$2M
100.00%
0.00%
A breakdown of Julie Smith's holdings
See the Top Stocks by Insiders

Insider Roles

Exelixis
(EXEL)
Director
Stoke Therapeutics
(STOK)
Director
Roles that Julie Smith holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Exelixis
(EXEL)
Rating:Informative Sell
Date:Feb 28, 2025 - Feb 28, 2026
Return:-13.80%
The most profitable trade made by Julie Smith
See the Latest Stocks Traded by Insiders

Julie Smith's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
STOK
Stoke Therapeutics
―
Director
―
―
RPTP
Raptor Pharmaceutical Corp.
Feb 11, 2016
―
Uninformative Buy
―
$341.55K
EXEL
Exelixis
May 29, 2026
Director
Uninformative Buy
―
$1.69M
~BOLD
Audentes Therapeutics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Julie Smith's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Julie Smith insider profile FAQ

What is the percentage of profitable transactions made by Julie Smith?
The percentage of profitable transactions made by Julie Smith is 0%.
    What is the average return per transaction made by Julie Smith?
    The average return per transaction made by Julie Smith is -47.00%.
      What stocks does Julie Smith hold?
      Julie Smith holds: STOK, RPTP, EXEL, ~BOLD stocks.
        What was Julie Smith’s latest transaction?
        Julie Smith latest transaction was an Uninformative Buy of ―.
          What was Julie Smith's most profitable transaction?
          Julie Smith’s most profitable transaction was an Informative Sell of EXEL stock on February 28, 2025. The return on the trade was -13.80%.
            What is Julie Smith's role in Stoke Therapeutics?
            Julie Smith's role in Stoke Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.